An Ultrapotent and Selective Cyclic Peptide Inhibitor of Human β-Factor XIIa in a Cyclotide Scaffold

2021 ◽  
Author(s):  
Wenyu Liu ◽  
Simon J. de Veer ◽  
Yen-Hua Huang ◽  
Toru Sengoku ◽  
Chikako Okada ◽  
...  
Keyword(s):  
Cyclic Peptide ◽  
Peptide Inhibitor ◽  
Factor Xiia

Elucidation of the Structure and Intermolecular Interactions of a Reversible Cyclic-Peptide Inhibitor of the Proteasome by NMR Spectroscopy and Molecular Modeling

2010 ◽  
Vol 122 (23) ◽  
pp. 4026-4030 ◽  
Author(s):  
Benjamin Stauch ◽  
Bernd Simon ◽  
Teodora Basile ◽  
Gisbert Schneider ◽  
Nisar P. Malek ◽  
...  
Keyword(s):  
Molecular Modeling ◽  
Nmr Spectroscopy ◽  
Intermolecular Interactions ◽  
Cyclic Peptide ◽  
Peptide Inhibitor

scholarly journals Development of a Cyclic Peptide Inhibitor of the p6/UEV Protein–Protein Interaction

2019 ◽  
Vol 14 (9) ◽  
pp. 1874-1878 ◽  
Author(s):  
Katherine R. Lennard ◽  
Reece M. Gardner ◽  
Cyrielle Doigneaux ◽  
Francisco Castillo ◽  
Ali Tavassoli
Keyword(s):  
Protein Interaction ◽  
Cyclic Peptide ◽  
Peptide Inhibitor ◽  
Protein Protein Interaction

scholarly journals Optimization of a Cyclic Peptide Inhibitor of Ser/Thr Phosphatase PPM1D (Wip1)

Biochemistry ◽  
2011 ◽  
Vol 50 (21) ◽  
pp. 4537-4549 ◽  
Author(s):  
Ryo Hayashi ◽  
Kan Tanoue ◽  
Stewart R. Durell ◽  
Deb K. Chatterjee ◽  
Lisa M. Miller Jenkins ◽  
...  
Keyword(s):  
Cyclic Peptide ◽  
Peptide Inhibitor

Elucidation of the Structure and Intermolecular Interactions of a Reversible Cyclic-Peptide Inhibitor of the Proteasome by NMR Spectroscopy and Molecular Modeling

2010 ◽  
Vol 49 (23) ◽  
pp. 3934-3938 ◽  
Author(s):  
Benjamin Stauch ◽  
Bernd Simon ◽  
Teodora Basile ◽  
Gisbert Schneider ◽  
Nisar P. Malek ◽  
...  
Keyword(s):  
Molecular Modeling ◽  
Nmr Spectroscopy ◽  
Intermolecular Interactions ◽  
Cyclic Peptide ◽  
Peptide Inhibitor

scholarly journals Structure-Based Drug Design of an Inhibitor of the SARS-CoV-2 (COVID-19) Main Protease Using Free Software: A Tutorial for Students and Scientists

2020 ◽  
Author(s):  
Sheng Zhang ◽  
Maj Krumberger ◽  
Michael A. Morris ◽  
Chelsea Marie T. Parrocha ◽  
James H. Griffin ◽  
...  
Keyword(s):  
Drug Design ◽  
Cyclic Peptide ◽  
Free Software ◽  
New Drugs ◽  
Peptide Inhibitor ◽  
Drug Candidate ◽  
Crystallographic Structure ◽  
Structure Based Drug Design ◽  
X Ray ◽  
Main Protease

This paper describes the structure-based design of a preliminary drug candidate against COVID-19 using free software and publicly available X-ray crystallographic structures. The goal of this tutorial is to disseminate skills in structure-based drug design and to allow others to unleash their own creativity to design new drugs to fight the current pandemic. The tutorial begins with the X-ray crystallographic structure of the main protease (M<sup>pro</sup>) of the SARS coronavirus (SARS-CoV) bound to a peptide substrate and then uses the UCSF Chimera software to modify the substrate to create a cyclic peptide inhibitor within the M<sup>pro</sup> active site. Finally, the tutorial uses the molecular docking software AutoDock Vina to show the interaction of the cyclic peptide inhibitor with both SARS-CoV M<sup>pro</sup> and the highly homologous SARS-CoV-2 M<sup>pro</sup>. The supporting information (supplementary material) provides an illustrated step-by-step protocol, as well as a video showing the inhibitor design process, to help readers design their own drug candidates for COVID-19 and the coronaviruses that will cause future pandemics. An accompanying preprint in bioRxiv [https://doi.org/10.1101/2020.08.03.234872] describes the synthesis of the cyclic peptide and the experimental validation as an inhibitor of SARS-CoV-2 M<sup>pro</sup>.

Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4–4), a Cyclic Peptide Inhibitor of MyD88

2019 ◽  
Vol 16 (4) ◽  
pp. 1516-1522
Author(s):  
Shira Dishon ◽  
Adi Schumacher-Klinger ◽  
Chaim Gilon ◽  
Amnon Hoffman ◽  
Gabriel Nussbaum
Keyword(s):  
Oral Bioavailability ◽  
Cyclic Peptide ◽  
Peptide Inhibitor

scholarly journals Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation

2007 ◽  
Vol 7 (1) ◽  
pp. 58 ◽  
Author(s):  
Corrine J Porter ◽  
Jacqueline M Matthews ◽  
Joel P Mackay ◽  
Sharon E Pursglove ◽  
Jason W Schmidberger ◽  
...  
Keyword(s):  
Cell Migration ◽  
Domain Structure ◽  
Cancer Cell ◽  
Cyclic Peptide ◽  
Sh2 Domain ◽  
Peptide Inhibitor ◽  
Cancer Cell Migration ◽  
Cell Migration And Proliferation

Solution Structure and Dynamics of G1TE, a Nonphosphorylated Cyclic Peptide Inhibitor for the Grb2 SH2 Domain

1999 ◽  
Vol 372 (2) ◽  
pp. 309-314 ◽  
Author(s):  
Yuan-Chao Lou ◽  
Feng-Di T. Lung ◽  
Ming-Tao Pai ◽  
Shiou-Ru Tzeng ◽  
Sue-Yee Wei ◽  
...  
Keyword(s):  
Solution Structure ◽  
Cyclic Peptide ◽  
Sh2 Domain ◽  
Peptide Inhibitor ◽  
Structure And Dynamics

scholarly journals Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy

2020 ◽  
Author(s):  
Wenjie Zhai ◽  
Xiuman Zhou ◽  
Mingxia Zhai ◽  
Wanqiong Li ◽  
Yunhui Ran ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Cyclic Peptide ◽  
Peptide Inhibitor

scholarly journals A cyclic peptide inhibitor of C-terminal binding protein dimerization links metabolism with mitotic fidelity in breast cancer cells

2013 ◽  
Vol 4 (8) ◽  
pp. 3046 ◽  
Author(s):  
Charles N. Birts ◽  
Sharandip K. Nijjar ◽  
Charlotte A. Mardle ◽  
Franciane Hoakwie ◽  
Patrick J. Duriez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Cyclic Peptide ◽  
Binding Protein ◽  
Peptide Inhibitor ◽  
Protein Dimerization
Sign in / Sign up

Export Citation Format

Share Document